Inflammatory myopathies

Nutritional interventions and dietary supplements in muscle diseases: a systematic review

Rheumatology (Oxford)Published Systematic review

Authors' conclusion

Evidence for nutritional interventions in muscle diseases remains limited, especially for inflammatory myopathies. The strongest support emerged for mechanistically targeted approaches: creatine with exercise, carbohydrate-rich and ketogenic diets in McArdle disease and sialic acid in GNE myopathy.

Study context

Population
Patients with muscle diseases (inflammatory myopathies, Duchenne muscular dystrophy, McArdle disease, GNE myopathy, critical illness myopathy)51 studies included
Comparison
Dietary interventions and supplements in muscle diseases
Outcome
Safety and efficacy of dietary interventions and supplements on muscle disease outcomes
Methodological detailsPRISMA-guided, registered on PROSPERO, multidisciplinary team
  • PRISMA-guided
  • Registered on PROSPERO
  • Multidisciplinary team

Pooled result

As reported in the abstract

  • Creatine (loading 20 g/day, maintenance 3 g/day) with exercise improved high-intensity functional performance in PM and DM over 6 months
  • Creatine (2-10 g/day for 8-16 weeks) improved maximal voluntary contraction and fatigue resistance in Duchenne muscular dystrophy
  • Carbohydrate-rich diets (65% CHO) reduced exercise-related symptoms in McArdle disease; high-dose creatine (150 mg/kg/day) paradoxically worsened symptoms
  • Aceneuramic acid (6 g/day for 48 weeks) in GNE myopathy: dose-dependent strength improvements in 4 trials, leading to regulatory approval in Japan
  • High-protein supplementation: positive trends for muscle preservation in critical illness myopathy
  • Most interventions used dietary supplements rather than whole dietary approaches

Further pooled results

Low risk of bias
31%
Some concerns
49%
High risk of bias
20%

Original publication

Nutritional interventions and dietary supplements in muscle diseases: a systematic review. Rheumatology (Oxford). Published 21 July 2026. doi:10.1093/rheumatology/keag378

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.